Oxalic Acid

Oxalic Acid

SCHEMBL31735151

CN1CCN(CCCNCc2ccc(-c3nc(-c4ccc(CNCCCN5CCN(C)CC5)cc4)c4ccsc4n3)cc2)CC1.O=C(O)C(=O)O

nearest known ligand 0.45

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

OPRM1SLC6A4

The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKT1 P31749 1/20 0.45
AKT2 P31751 1/20 0.45
KMT2A Q03164 4/20 0.40
RAD52 P43351 3/20 0.40
MEN1 O00255 3/20 0.40
ACKR3 P25106 1/20 0.40
HDAC1 Q13547 1/20 0.39
KDM4E B2RXH2 1/20 0.38
ALDH1A1 P00352 1/20 0.38
LMNA P02545 1/20 0.38
TP53 P04637 1/20 0.38
POLB P06746 1/20 0.38
HPGD P15428 1/20 0.38
AHR P35869 1/20 0.38
STAT3 P40763 1/20 0.38
HTT P42858 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
HSD17B10 Q99714 1/20 0.38
RCE1 Q9Y256 1/20 0.38
PDE4B Q07343 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29680577 0.94 AKT1 (0.47) AKT1AKT2KMT2ARAD52MEN1
Oxalic Acid SCHEMBL31735159 0.86 AKT1 (0.46) AKT1AKT2KMT2ARAD52MEN1
Oxalic Acid SCHEMBL29680295 0.85 AKT1 (0.46) AKT1AKT2KMT2ARAD52MEN1
Oxalic Acid SCHEMBL29680443 0.81 AKT1 (0.46) AKT1AKT2KMT2ARAD52MEN1
SCHEMBL29680541 0.80 AKT1 (0.47) AKT1AKT2RAD52ACKR3PDE4B
SCHEMBL29680354 0.79 AKT1 (0.48) AKT1AKT2KMT2ARAD52MEN1
Oxalic Acid SCHEMBL29680369 0.77 KDM5B (0.51) AKT1AKT2
Oxalic Acid SCHEMBL29680236 0.76 AKT1 (0.46) AKT1AKT2KMT2ARAD52MEN1
SCHEMBL29680888 0.75 AKT1 (0.49) AKT1AKT2RAD52HDAC1POLB
Oxalic Acid SCHEMBL29680612 0.73 AKT1 (0.46) AKT1AKT2KMT2ARAD52MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250360134-A1 6-6 OR 5-6 FUSED BICYCLIC COMPOUNDS COMPRISING A PYRI(MI)DINE RING USEFUL IN THE|TREATMENT OF INFECTIOUS DISEASES INST NAT SANTE RECH MED (FR) 2025-11-27 US claimed
US-20250360134-A1 6-6 OR 5-6 FUSED BICYCLIC COMPOUNDS COMPRISING A PYRI(MI)DINE RING USEFUL IN THE|TREATMENT OF INFECTIOUS DISEASES INST NAT SANTE RECH MED (FR) 2025-11-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250360134-A1 6-6 OR 5-6 FUSED BICYCLIC COMPOUNDS COMPRISING A PYRI(MI)DINE RING USEFUL IN THE|TREATMENT OF INFECTIOUS DISEASES SARS1, CCR5, INTS6 AKT1 4342/4885AKT2 4315/4885KMT2A 3460/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.